Cogent Biosciences to Participate in the Guggenheim Biotech Conference
WALTHAM, Mass. and BOULDER, Colo., Jan. 30, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: COGT), a biotechnology company focused on ...
Cogent Biosciences (NASDAQ:COGT) Shares Down 4.2% – What’s Next?
Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report)’s share price traded down 4.2% during mid-day trading on Friday . The stock traded as low as $8.54 and last traded at $8.52. 272,611 shares ...
Business Insider21d
Cogent Biosciences Announces Planned 2025 Milestones for Bezuclastinib and Emerging Portfolio of Selective and Potent Targeted Therapeutics
and BOULDER, Colo., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases ...
This Cogent Biosciences Insider Increased Their Holding By 2,085% Last Year
Looking at Cogent Biosciences, Inc.'s ( NASDAQ:COGT ) insider transactions over the last year, we can see that ...
news.stocktradersdaily4d
How the (COGT) price action is used to our Advantage
Check the time stamp on this data. Updated AI-Generated Signals for Cogent Biosciences Inc. (COGT) available here: COGT. Type ...
Business Insider4d
Cogent Biosciences to Participate in the Guggenheim Biotech Conference
WALTHAM, Mass. and BOULDER, Colo., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision ...
Cogent Biosciences Announces Planned 2025 Milestones for Bezuclastinib and Emerging Portfolio of Selective and Potent Targeted Therapeutics
Report top-line results during the second half of 2025 from the APEX trial. APEX is a registration-directed, global, ...